Eidos治疗(EIDX)

122.21 0.00 0.0%

今开:0.0昨收:122.21
最高:0.0 最低:0.0
涨停价:0.0跌停价:0.0
总市值:4.74931561E9

Eidos治疗的热门讨论

Eidos治疗(EIDX)2020-10-03 07:48

$Eidos治疗(EIDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-026974  Size: 8 KB 网页链接查看全文

Eidos治疗(EIDX)2020-10-06 18:06

$Eidos治疗(EIDX)$ 425 Prospectuses and communications, business combinations Accession Number: 0001193125-20-264235  Act: 34  Size: 107 KB 网页链接查看全文

Eidos治疗(EIDX)2020-10-06 04:18

$Eidos治疗(EIDX)$ 425 Prospectuses and communications, business combinations Accession Number: 0001193125-20-263876  Act: 34  Size: 63 KB 网页链接查看全文

Eidos治疗(EIDX)2020-10-06 05:36

$Eidos治疗(EIDX)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-20-264026  Act: 34  Size: 557 KB 网页链接查看全文

Eidos治疗(EIDX)2020-10-08 05:06

$Eidos治疗(EIDX)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-20-113116  Act: 34  Size: 67 KB 网页链接查看全文

美股马甲2020-10-05 19:26

$Eidos治疗(EIDX)$ 总算被bbio全收了查看全文

Eidos治疗(EIDX)2019-08-13 11:30

$Eidos治疗(EIDX)$ 8-K - Current report Filed: 2019-08-12 AccNo: 0001193125-19-219038 Size: 34 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接查看全文

Eidos治疗(EIDX)2020-09-29 19:21

$Eidos治疗(EIDX)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001193125-20-257175  Act: 34  Size: 11 MB 网页链接查看全文

Eidos治疗(EIDX)2020-09-19 07:36

$Eidos治疗(EIDX)$ 内部交易: 2020-09-17,See Remarks,Fox Jonathan C ,卖出,5767普通股, $50.16查看全文

Eidos治疗(EIDX)2020-09-19 04:12

$Eidos治疗(EIDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-025694  Size: 6 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Eidos治疗的最新讨论

chuminhua2020-12-15 11:33

12/14,据彭博社援引匿名消息来源的报道称,Eidos Therapeutics于11月收到葛兰素史克(GlaxoSmithKline)的收购要约。Eidos已经同意BridgeBio Pharma的收购要约,该公司在最近的一份文件中披露,“大型国际制药公司”在11月下旬以每股120美元的全现金,无约束力的出价竞标了Eidos。
据彭博社报...查看全文

美股马甲2020-10-05 19:26

$Eidos治疗(EIDX)$ 总算被bbio全收了查看全文

chuminhua2019-10-20 23:11

10/14,BridgeBio Pharma$BridgeBio Pharma(BBIO)$ 放弃收购其子公司Eidos Therapeutics$Eidos治疗(EIDX)$ 。2017年BridgeBio创办了Eidos以开发AG10,这是用于转甲状腺素蛋白淀粉样变性的药物。第二年,Eidos上市,BridgeBio拥有该公司66%的股份。BridgeBio原计划今年早些时候收购该公司剩余的34%...查看全文

Replix锐璞美股2019-06-27 14:04

$Adaptive生物技术(ADPT)$ /$BridgeBio Pharma(BBIO)$ -明天IPO,ADPT定价$20, BBIO定价 $17, 从定价来看两家公司都比较受市场欢迎。流通股的数量都差不多,123M左右。Viking Global 都是两家的大股东。ADPT走的是当下热点Computational Biology/Machine Learning。BBIO走的是VC模式,持有$Eidos治...查看全文

美股律师郝俊波2019-04-02 10:48

$Eidos治疗(EIDX)$ Eidos Therapeutics Inc(NASDAQ: EIDX)因突发不利消息而令股价下跌,如果您投资该证券受损请点击我们的雪球网EIDX集体诉讼专题页:网页链接查看全文

群氓鄙陋2018-11-13 23:56

$Eidos Therapeutics(EIDX)$$Scholar Rock Holding(SRRK)$ 依然比较坚挺,另一只就有点歇菜了查看全文

淘沙见金2018-11-11 01:08

$Eidos Therapeutics(EIDX)$ 非常不错的数据! AG10 Resulted in Average TTR Stabilization Greater than 90% in All Actively Treated Subjects at Day 28. AG10 Significantly Raised Serum TTR Concentrations (p<0.0001) by 50% and 36% in Subjects Administered 800 mg Twice Daily and ...查看全文

2018年11月重点关注标的

greenlandbiotech2018-10-24 03:34

这一次11月的重点关注标的我们特意提前发布,主要是最近市场对小市值药股无论positive还是negative的消息都进行卖空的行为,使得我们需要去适应市场的改变,因此,更建议大家更早的投资那些有着爆点的且值得投资的标的,我们重点推荐关注NASH市场的VKTX(12号) MDGL(12号) GLMD(13号)在11月...查看全文

淘沙见金2018-08-28 20:05

$Eidos Therapeutics(EIDX)$ $辉瑞(PFE)$ 对数据分析的比较详细[牛][牛][牛]查看全文

1 2

Eidos治疗的公告

$Eidos治疗(EIDX)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-21-017733  Size: 29 KB 网页链接

$Eidos治疗(EIDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-21-003286  Size: 7 KB 网页链接

$Eidos治疗(EIDX)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001193125-21-017696  Act: 33  Size: 22 KB 网页链接

$Eidos治疗(EIDX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-017697  Act: 33  Size: 23 KB 网页链接

$Eidos治疗(EIDX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-017698  Act: 33  Size: 23 KB 网页链接

$Eidos治疗(EIDX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-017699  Act: 33  Size: 23 KB 网页链接

$Eidos治疗(EIDX)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-21-017128  Act: 34  Size: 33 KB 网页链接

$Eidos治疗(EIDX)$ 8-K Current report, items 1.01, 2.01, 2.03, 3.01, 3.03, 5.01, 5.02, 5.03, and 9.01 Accession Number: 0001193125-21-017109  Act: 34  Size: 381 KB 网页链接

$Eidos治疗(EIDX)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-21-000105  Act: 34  Size: 2 KB 网页链接

$Eidos治疗(EIDX)$ 8-K Current report, items 5.07, 8.01, and 9.01 Accession Number: 0001193125-21-012447  Act: 34  Size: 208 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15